173 research outputs found
Evidence-based medicine: new in the search for evidence
The review is focused on discussing new trends in DM, rethinking the evidence base medicine with an emphasis on demonstrating the efficacy and safety of new therapeutic agents and medical technologies, from gene editing to AI algorithms. At the same time, clinical trials of drugs are also not standing still, there is active development, new approaches, methods and designs are being developed. The process of drug development, registration and market launch of any drug takes a significant period of time, requires high financial costs and human resources. The gold standard of evidence-based medicine was initially considered to be RCTs, but at the same time, they have objective disadvantages: limited sample, inability to control all factors; insufficient follow-up time,negative impact on participants, inability to determine cause-and-effect relationships; limited measurement methods, limited budget and others. This review discusses the trends in the methodology of clinical research. The active implementation of new designs such as Adaptive Clinical Trials, "Master" protocols including Umbrella Study, Basket Study, Platform Studies, Master Observational Trials and the increased use of Single Patient Trials (N-of-1 trials) are allowing studies to become more efficient, relevant and applicable to real-life health care practice settings and patient-centered. In the review, we also look at both the pros and cons of the expanded use of biomarkers and Digital Endpoints in clinical trials and virtual clinical trials, which use mathematical models to study patient heterogeneity and its impact on various therapeutic questions. The process of expertise and regulatory approval continues to slow down the entry of drugs into the pharmaceutical market. The review considers changes in the approaches of regulators (FDA, EMEA and Russian Ministry of Health) to the drug registration procedure. The COVID-19 pandemic and sanctions have led to the need to expand the list of drugs with authorized accelerated registration. However, accelerated registration raises many questions regarding the sufficiency of the level of evidence and safety. As we can see a deep synthesis and integration of all available data is needed to achieve the next generation of evidence-based medicine. The major challenge in the next two decades will be to exploit the potential of multidimensional evidence generation by extracting, collating and generating large data sets of natural course of disease, genomics and all other omics analyses, all published clinical trials, RWD to provide next generation evidence
Systemic characteristic of safety profile of monoclonal antibodies used in rheumatology practice
Monoclonal antibodies are highly effective medications, which made a breakthrough in medicine. Taking into consideration the properties of monoclonal antibodies safety plays a key role in βrisk-benefitβ assessment. For monoclonal antibodies this remains studied insufficiently. The article presents a systemic characteristic of safety profile of monoclonal antibodies used in rheumatology, based on the database of spontaneous reports of the Federal Service for the Supervision of Healthcare. Specified greater alertness of Russian practitioners regarding the risk of developing tuberculosis infections in comparison to their foreign counterparts. Spontaneous reports of the development of neoplasms and deviations of laboratory tests, according to our data, on the contrary, are reported less. It is advisable to draw the attention of practitioners to the peculiarities of work with isolated deviations in laboratory tests and keep alert about the safety issues of monoclonal antibodies in general. It is important to continue monitoring to characterize delayed type D adverse drug reactions
Recommended from our members
Long term instability in the defect assembly in irradiated high resistivity silicon detectors
Different kinetic behavior has been revealed for the two types of irradiated high resistivity silicon detectors in the reactions of the interstitial carbon (C{sub i}) annealing and the formation of the C{sub i}-O{sub i} complex. In the detectors with an increased oxygen contents prolonged growth of the C{sub i}-O{sub i} complex concentration obeyed the second order reaction due to an additional source of C{sub i} atoms which were not detected by DLTS measurements. Transformation of carbon related defects has been analyzed concerning the long term instability of irradiated silicon detectors. 5 refs., 2 figs
Safety issues of monoclonal antibodies used in rheumatology
Success in practical rheumatology of the latest decade achieved mainly due to monoclonal antibodies (MABs) appearance in routine medical practice. At the same time, the experience of practical application of MABs is limited both by observation period and exposure and their clinical and pharmacological properties do not allow to fully characterizing their safety profile with the data from clinical studies. The use of MABs is associated with the risk of delayed adverse drug reactions (ADRs) β types B (immunoallergic reactions), C (new diseases) and D (delayed teratogenic and oncogenic effects). Determination of risk factors in real medical evidence is especially important. The risk factors of ADRs including serious ADRs were studied based on an analysis of the spontaneous reports database of the Federal Service for Supervision in Healthcare and the data from rheumatologic register of patients receiving MABs β the E.E. Eikhvald Clinic in North-Western State Medical University named after I.I. Mechnikov. It was shown that the factors coming from the patient (gender, age group) do not affect the severity of the risk of occurrence of ADR, including serious ADRs, while the risk factor for monoclonal antibodies can be considered the choice of tocilizumab, which increases the risk of serious ADRs
Recommended from our members
Scanning transient current study of the I-V stabilization phenomena in silicon detectors irradiated by fast neutrons
Investigation of the I-V stabilization phenomena in neutron irradiated silicon detectors has been carried out using scanning transient current technique (STCT) on non-irradiated PP{sup +}-p-n{sup +} detectors. The PP{sup +}-p-n{sup +} detectors were used to simulate the PP{sup +}-n-n{sup +} detectors irradiated beyond the space charge sign inversion (SCSI). Two mechanisms partially responsible for the I- V stabilization have been identified
Factors associated with adverse outcome among hospitalized patients with moderate to severe COVID-19
Aims. To consider factors associated with adverse outcome among hospitalized patients with moderate and severe COVID-19.Materials and methods. Data from 345 case histories of adult patients hospitalized with moderate to severe COVID-19 were analyzed in a single-center retrospective study. Characteristics by sex, age, number of days from disease onset to admission to hospital, duration of hospitalization, duration of disease, population characteristics by medical history of comorbidities and self-medication, outcome of hospitalization and medical technologies used in hospital conditions were given for the whole cohort of patients. All parameters were analyzed using descriptive statistics methods. Qualitative variables are given in absolute (n) and relative (%) values with 95% confidence interval. Continuous variables were presented as median and quartiles. Risk factors for mortality were determined across groups using the Ο2 Β criterion and odds ratio.Results. There was no demonstrated effect of gender, degree of pulmonary tissue lesions on computed tomography data, or time of initiation of respiratory support on disease outcome. At the same time, the age older than 65 years as well as neoplasms, type 2 diabetes mellitus, dementia, Stage 3 arterial hypertension, chronic heart failure, coronary heart disease, myocardial infarction and stroke history, chronic obstructive pulmonary disease, bronchiectatic disease, urogenital diseases were the predictors of unfavorable outcome in patients with moderate and severe COVID-19 form. Prehospital use of antiplatelet agents, direct and indirect oral anticoagulants, drugs affecting the renin-angiotensin system, systemic glucocorticosteroids, antibiotics, antiviral drugs, and analgesics was associated with a decrease in the mortality rate in patients with moderate-to-severe COVID-19, as well as timely use of pronposition and transfer to intensive care unit.Conclusions. Our findings are partially consistent with previous reports on the effect of risk factors on COVID-19 outcomes
Investigation of epitaxial silicon layers as a material for radiation hardened silicon detectors
Epitaxial grown thick layers ({ge} 100 micrometers) of high resistivity silicon (Epi-Si) have been investigated as a possible candidate of radiation hardened material for detectors for high-energy physics. As grown Epi-Si layers contain high concentration (up to 2 {times} 10{sup 12} cm{sup {minus}3}) of deep levels compared with that in standard high resistivity bulk Si. After irradiation of test diodes by protons (E{sub p} = 24 GeV) with a fluence of 1.5 {times} 10{sup 11} cm{sup {minus}2}, no additional radiation induced deep traps have been detected. A reasonable explanation is that there is a sink of primary radiation induced defects (interstitial and vacancies), possibly by as-grown defects, in epitaxial layers. The ``sinking`` process, however, becomes non-effective at high radiation fluences (10{sup 14} cm{sup {minus}2}) due to saturation of epitaxial defects by high concentration of radiation induced ones. As a result, at neutron fluence of 1 {times} 10{sup 14} cm{sup {minus}2} the deep level spectrum corresponds to well-known spectrum of radiation induced defects in high resistivity bulk Si. The net effective concentration in the space charge region equals to 3 {times} 10{sup 12} cm{sup {minus}3} after 3 months of room temperature storage and reveals similar annealing behavior for epitaxial as compared to bulk silicon
Π‘ΠΊΡΡΡΠ°Ρ ΠΊΠ°Π΄ΡΠΎΠ²Π°Ρ ΠΏΡΠΎΠ±Π»Π΅ΠΌΠ° ΡΠΎΡΡΠΈΠΉΡΠΊΠΎΠΉ ΠΈΠ½Π½ΠΎΠ²Π°ΡΠΈΠΎΠ½Π½ΠΎΠΉ ΡΠΊΠΎΠ½ΠΎΠΌΠΈΠΊΠΈ: ΠΏΠΎΡΠ΅Π½ΡΠΈΠ°Π» ΡΠΈΡΡΠ΅ΠΌΡ ΠΏΡΠΎΡΠ΅ΡΡΠΈΠΎΠ½Π°Π»ΡΠ½ΠΎ-ΠΏΠ΅Π΄Π°Π³ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΎΠ±ΡΠ°Π·ΠΎΠ²Π°Π½ΠΈΡ
The article is devoted to the necessity of development of the system of vocational pedagogic education from the position of importance of vocational education teacherβs training which can create a real opportunity to solve the problem of understaffing and middle manager supply in Russian innovative economy.Π‘ΡΠ°ΡΡΡ ΠΏΠΎΡΠ²ΡΡΠ΅Π½Π° ΠΎΠ±ΠΎΡΠ½ΠΎΠ²Π°Π½ΠΈΡ Π½Π΅ΠΎΠ±Ρ
ΠΎΠ΄ΠΈΠΌΠΎΡΡΠΈ ΡΠ°Π·Π²ΠΈΡΠΈΡ ΡΠΈΡΡΠ΅ΠΌΡ ΠΏΡΠΎΡΠ΅ΡΡΠΈΠΎΠ½Π°Π»ΡΠ½ΠΎ-ΠΏΠ΅Π΄Π°Π³ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΎΠ±ΡΠ°Π·ΠΎΠ²Π°Π½ΠΈΡ Ρ ΠΏΠΎΠ·ΠΈΡΠΈΠΈ Π²Π°ΠΆΠ½ΠΎΡΡΠΈ ΠΏΠΎΠ΄Π³ΠΎΡΠΎΠ²ΠΊΠΈ ΠΏΠ΅Π΄Π°Π³ΠΎΠ³ΠΎΠ² ΠΏΡΠΎΡΠ΅ΡΡΠΈΠΎΠ½Π°Π»ΡΠ½ΠΎΠ³ΠΎ ΠΎΠ±ΡΡΠ΅Π½ΠΈΡ Π΄Π»Ρ ΡΠΎΠ·Π΄Π°Π½ΠΈΡ ΡΠ΅Π°Π»ΡΠ½ΠΎΠΉ Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎΡΡΠΈ ΡΠ΅ΡΠ΅Π½ΠΈΡ ΠΏΡΠΎΠ±Π»Π΅ΠΌΡ ΠΎΠ±Π΅ΡΠΏΠ΅ΡΠ΅Π½Π½ΠΎΡΡΠΈ ΠΈΠ½Π½ΠΎΠ²Π°ΡΠΈΠΎΠ½Π½ΠΎΠΉ ΡΠΊΠΎΠ½ΠΎΠΌΠΈΠΊΠΈ Π ΠΎΡΡΠΈΠΈ ΡΠ°Π±ΠΎΡΠΈΠΌΠΈ ΠΊΠ°Π΄ΡΠ°ΠΌΠΈ ΠΈ ΡΠΏΠ΅ΡΠΈΠ°Π»ΠΈΡΡΠ°ΠΌΠΈ ΡΡΠ΅Π΄Π½Π΅Π³ΠΎ Π·Π²Π΅Π½Π°.ΠΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ Π²ΡΠΏΠΎΠ»Π½Π΅Π½Ρ ΠΏΡΠΈ ΡΠΈΠ½Π°Π½ΡΠΎΠ²ΠΎΠΉ ΠΏΠΎΠ΄Π΄Π΅ΡΠΆΠΊΠ΅ Π ΠΠΠ€ (Π³ΡΠ°Π½Ρ Π ΠΠΠ€ 07-06-00606-Π° ΠΏΠΎ ΠΏΡΠΎΠ΅ΠΊΡΡ Β«Π Π°Π·ΡΠ°Π±ΠΎΡΠΊΠ° ΠΊΠΎΠΌΠΏΠ΅ΡΠ΅Π½ΡΠ½ΠΎΡΡΠ½ΠΎΠΉ ΠΌΠΎΠ΄Π΅Π»ΠΈ ΠΏΠΎΠ΄Π³ΠΎΡΠΎΠ²ΠΊΠΈ ΡΠΏΠ΅ΡΠΈΠ°Π»ΠΈΡΡΠΎΠ² ΠΏΠΎ ΠΎΠ±ΡΡΠ΅Π½ΠΈΡ ΡΠ°Π±ΠΎΡΠΈΡ
ΠΊΠ°Π΄ΡΠΎΠ² Π΄Π»Ρ ΠΈΠ½Π½ΠΎΠ²Π°ΡΠΈΠΎΠ½Π½ΡΡ
ΠΏΡΠΎΠΈΠ·Π²ΠΎΠ΄ΡΡΠ²Π΅Π½Π½ΡΡ
ΡΠ΅Ρ
Π½ΠΎΠ»ΠΎΠ³ΠΈΠΉ ΠΈ ΠΈΠ½Π½ΠΎΠ²Π°ΡΠΈΠΎΠ½Π½ΡΡ
ΡΠ΅Ρ
Π½ΠΎΠΏΠ°ΡΠΊΠΎΠ²Β»)
ΠΠΎΠ²ΡΠΉ ΠΈΡΡ ΠΎΠ΄Π½ΡΠΉ ΠΌΠ°ΡΠ΅ΡΠΈΠ°Π» Π΄Π»Ρ ΡΠΎΠ·Π΄Π°Π½ΠΈΡ ΠΏΠ΅ΡΡΠΏΠ΅ΠΊΡΠΈΠ²Π½ΡΡ ΡΠΎΡΡΠΎΠ² Π΄ΡΠ½ΠΈ
Relevance. The creation of varieties with a complex of economically valuable traits, resistant to biotic and abiotic environmental factors, is the main direction in melon breeding. The market for vegetables and melons and gourds is very dynamic, the demands for varieties are constantly changing, therefore, it is necessary to introduce new varieties with high taste and commercial qualities, as well as capable of producing high yields in a changing climate. The aim of the work is to produce a new melon starting material for use in the breeding process.Materials and methods. At the Bikovskaya cucurbits breeding experimental station β branch of the Federal state budgetary scientific institution "Federal scientific vegetable center", research was carried out from 2018 to 2020. The object of research is samples from the collection of VIR, foreign and domestic selection, hybrid combinations obtained as a result of intervarietal hybridization. Collection samples of melon were studied in the nursery of the source material: 84 samples from the VIR collection, 26 samples of domestic and foreign selection were studied.Results. As a result of the research, samples of melon with economically valuable traits were identified that meet the requirements of selection. Paired crosses with zoned varieties of local selection were carried out with them. As a result of hybridization, hybrid combinations F1 were obtained, from which the best ones were selected for further breeding work. The obtained collection samples and hybrid combinations were evaluated in terms of taste, yield, resistance to environmental abiofactors, dry matter content, large-fruited, attractive color of the fruit and pulp As a result received a new source material for the selection of new varieties and hybrids of melons with valuable economic traits. The resulting hybrid combinations of F1 melon were tested against an infectious background. Hybrid combinations with the best performance will be further studied in a breeding nursery.ΠΠΊΡΡΠ°Π»ΡΠ½ΠΎΡΡΡ. Π‘ΠΎΠ·Π΄Π°Π½ΠΈΠ΅ ΡΠΎΡΡΠΎΠ², ΠΎΠ±Π»Π°Π΄Π°ΡΡΠΈΡ
ΠΊΠΎΠΌΠΏΠ»Π΅ΠΊΡΠΎΠΌ Ρ
ΠΎΠ·ΡΠΉΡΡΠ²Π΅Π½Π½ΠΎ ΡΠ΅Π½Π½ΡΡ
ΠΏΡΠΈΠ·Π½Π°ΠΊΠΎΠ², ΡΡΡΠΎΠΉΡΠΈΠ²ΡΡ
ΠΊ Π±ΠΈΠΎΡΠΈΡΠ΅ΡΠΊΠΈΠΌ ΠΈ Π°Π±ΠΈΠΎΡΠΈΡΠ΅ΡΠΊΠΈΠΌ ΡΠ°ΠΊΡΠΎΡΠ°ΠΌ ΡΡΠ΅Π΄Ρ, ΡΠ²Π»ΡΠ΅ΡΡΡ Π³Π»Π°Π²Π½ΡΠΌ Π½Π°ΠΏΡΠ°Π²Π»Π΅Π½ΠΈΠ΅ΠΌ Π² ΡΠ΅Π»Π΅ΠΊΡΠΈΠΎΠ½Π½ΠΎΠΉ ΡΠ°Π±ΠΎΡΠ΅ ΠΏΠΎ Π΄ΡΠ½Π΅. Π ΡΠ½ΠΎΠΊ ΠΎΠ²ΠΎΡΠ½ΠΎΠΉ ΠΈ Π±Π°Ρ
ΡΠ΅Π²ΠΎΠΉ ΠΏΡΠΎΠ΄ΡΠΊΡΠΈΠΈ ΠΎΡΠ΅Π½Ρ Π΄ΠΈΠ½Π°ΠΌΠΈΡΠ΅Π½, Π·Π°ΠΏΡΠΎΡΡ Π½Π° ΡΠΎΡΡΠ° ΠΏΠΎΡΡΠΎΡΠ½Π½ΠΎ ΠΌΠ΅Π½ΡΡΡΡΡ, ΠΏΠΎΡΡΠΎΠΌΡ ΡΡΠ΅Π±ΡΠ΅ΡΡΡ Π²Π½Π΅Π΄ΡΠ΅Π½ΠΈΠ΅ Π½ΠΎΠ²ΡΡ
ΡΠΎΡΡΠΎΠ², ΠΎΠ±Π»Π°Π΄Π°ΡΡΠΈΡ
Π²ΡΡΠΎΠΊΠΈΠΌΠΈ Π²ΠΊΡΡΠΎΠ²ΡΠΌΠΈ ΠΈ ΡΠΎΠ²Π°ΡΠ½ΡΠΌΠΈ ΠΊΠ°ΡΠ΅ΡΡΠ²Π°ΠΌΠΈ, Π° ΡΠ°ΠΊΠΆΠ΅ ΡΠΏΠΎΡΠΎΠ±Π½ΡΡ
Π΄Π°Π²Π°ΡΡ Π²ΡΡΠΎΠΊΠΈΠ΅ ΡΡΠΎΠΆΠ°ΠΈ Π² ΡΡΠ»ΠΎΠ²ΠΈΡΡ
ΠΈΠ·ΠΌΠ΅Π½ΡΡΡΠ΅Π³ΠΎΡΡ ΠΊΠ»ΠΈΠΌΠ°ΡΠ°. Π¦Π΅Π»Ρ ΡΠ°Π±ΠΎΡΡ β ΡΠΎΠ·Π΄Π°ΡΡ Π½ΠΎΠ²ΡΠΉ ΠΈΡΡ
ΠΎΠ΄Π½ΡΠΉ ΠΌΠ°ΡΠ΅ΡΠΈΠ°Π» Π΄ΡΠ½ΠΈ, ΠΎΠ±Π»Π°Π΄Π°ΡΡΠΈΠΉ ΠΏΠ°ΡΠ°ΠΌΠ΅ΡΡΠ°ΠΌΠΈ, Π½Π΅ΠΎΠ±Ρ
ΠΎΠ΄ΠΈΠΌΡΠΌΠΈ ΡΠ΅Π»Π΅ΠΊΡΠΈΠΎΠ½Π΅ΡΡ ΡΠΎΠ³Π»Π°ΡΠ½ΠΎ ΡΠ°Π·ΡΠ°Π±ΠΎΡΠ°Π½Π½ΠΎΠΉ ΠΌΠΎΠ΄Π΅Π»ΠΈ ΡΠΎΡΡΠ°.ΠΠ°ΡΠ΅ΡΠΈΠ°Π»Ρ ΠΈ ΠΌΠ΅ΡΠΎΠ΄Ρ. ΠΠ±ΡΠ΅ΠΊΡ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ β ΠΎΠ±ΡΠ°Π·ΡΡ ΠΈΠ· ΠΊΠΎΠ»Π»Π΅ΠΊΡΠΈΠΈ ΠΠΠ , Π·Π°ΡΡΠ±Π΅ΠΆΠ½ΠΎΠΉ ΠΈ ΠΎΡΠ΅ΡΠ΅ΡΡΠ²Π΅Π½Π½ΠΎΠΉ ΡΠ΅Π»Π΅ΠΊΡΠΈΠΈ, Π³ΠΈΠ±ΡΠΈΠ΄Π½ΡΠ΅ ΠΊΠΎΠΌΠ±ΠΈΠ½Π°ΡΠΈΠΈ, ΠΏΠΎΠ»ΡΡΠ΅Π½Π½ΡΠ΅ Π² ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠ΅ ΠΌΠ΅ΠΆΡΠΎΡΡΠΎΠ²ΠΎΠΉ Π³ΠΈΠ±ΡΠΈΠ΄ΠΈΠ·Π°ΡΠΈΠΈ. ΠΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ ΠΏΡΠΎΠ²ΠΎΠ΄ΠΈΠ»ΠΈ Π½Π° ΠΡΠΊΠΎΠ²ΡΠΊΠΎΠΉ ΡΠ΅Π»Π΅ΠΊΡΠΈΠΎΠ½Π½ΠΎΠΉ ΠΎΠΏΡΡΠ½ΠΎΠΉ ΡΡΠ°Π½ΡΠΈΠΈ β ΡΠΈΠ»ΠΈΠ°Π»Π΅ Π€ΠΠΠΠ£ Π€ΠΠ¦Π Π² 2018-2020 Π³ΠΎΠ΄Π°Ρ
. Π ΠΏΠΈΡΠΎΠΌΠ½ΠΈΠΊΠ΅ ΠΈΡΡ
ΠΎΠ΄Π½ΠΎΠ³ΠΎ ΠΌΠ°ΡΠ΅ΡΠΈΠ°Π»Π° ΠΈΠ·ΡΡΠ°Π»ΠΈ ΠΊΠΎΠ»Π»Π΅ΠΊΡΠΈΠΎΠ½Π½ΡΠ΅ ΠΎΠ±ΡΠ°Π·ΡΡ Π΄ΡΠ½ΠΈ: 84 ΠΎΠ±ΡΠ°Π·ΡΠ° ΠΈΠ· ΠΊΠΎΠ»Π»Π΅ΠΊΡΠΈΠΈ ΠΠΠ , 26 ΠΎΠ±ΡΠ°Π·ΡΠΎΠ² ΠΎΡΠ΅ΡΠ΅ΡΡΠ²Π΅Π½Π½ΠΎΠΉ ΠΈ ΠΈΠ½ΠΎΡΡΡΠ°Π½Π½ΠΎΠΉ ΡΠ΅Π»Π΅ΠΊΡΠΈΠΈ. ΠΡΠ΅Π½ΠΈΠ²Π°Π»ΠΈ ΠΏΠΎΠ»ΡΡΠ΅Π½Π½ΡΠ΅ ΠΊΠΎΠ»Π»Π΅ΠΊΡΠΈΠΎΠ½Π½ΡΠ΅ ΠΎΠ±ΡΠ°Π·ΡΡ ΠΈ Π³ΠΈΠ±ΡΠΈΠ΄Π½ΡΠ΅ ΠΊΠΎΠΌΠ±ΠΈΠ½Π°ΡΠΈΠΈ ΠΏΠΎ Π²ΠΊΡΡΠΎΠ²ΡΠΌ ΠΊΠ°ΡΠ΅ΡΡΠ²Π°ΠΌ, ΡΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΡ ΡΡΡ
ΠΎΠ³ΠΎ Π²Π΅ΡΠ΅ΡΡΠ²Π°, ΡΡΠΎΠΆΠ°ΠΉΠ½ΠΎΡΡΠΈ, ΡΡΡΠΎΠΉΡΠΈΠ²ΠΎΡΡΠΈ ΠΊ Π°Π±ΠΈΠΎΡΠ°ΠΊΡΠΎΡΠ°ΠΌ ΡΡΠ΅Π΄Ρ, ΠΊΡΡΠΏΠ½ΠΎΠΏΠ»ΠΎΠ΄Π½ΠΎΡΡΠΈ, ΠΏΡΠΈΠ²Π»Π΅ΠΊΠ°ΡΠ΅Π»ΡΠ½ΠΎΠΉ ΠΎΠΊΡΠ°ΡΠΊΠ΅ ΠΏΠ»ΠΎΠ΄Π° ΠΈ ΠΌΡΠΊΠΎΡΠΈ.Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ. ΠΡΠ΄Π΅Π»Π΅Π½Ρ ΠΎΠ±ΡΠ°Π·ΡΡ Π΄ΡΠ½ΠΈ Ρ Ρ
ΠΎΠ·ΡΠΉΡΡΠ²Π΅Π½Π½ΠΎ ΡΠ΅Π½Π½ΡΠΌΠΈ ΠΏΡΠΈΠ·Π½Π°ΠΊΠ°ΠΌΠΈ, ΠΊΠΎΡΠΎΡΡΠ΅ ΠΎΡΠ²Π΅ΡΠ°ΡΡ ΡΡΠ΅Π±ΠΎΠ²Π°Π½ΠΈΡΠΌ ΡΠ΅Π»Π΅ΠΊΡΠΈΠΈ. ΠΡΠΎΠ²Π΅Π»ΠΈ ΠΏΠ°ΡΠ½ΡΠ΅ ΡΠΊΡΠ΅ΡΠΈΠ²Π°Π½ΠΈΡ Ρ ΡΠ°ΠΉΠΎΠ½ΠΈΡΠΎΠ²Π°Π½Π½ΡΠΌΠΈ ΡΠΎΡΡΠ°ΠΌΠΈ ΠΌΠ΅ΡΡΠ½ΠΎΠΉ ΡΠ΅Π»Π΅ΠΊΡΠΈΠΈ. Π ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠ΅ Π³ΠΈΠ±ΡΠΈΠ΄ΠΈΠ·Π°ΡΠΈΠΈ ΠΏΠΎΠ»ΡΡΠ΅Π½Ρ Π³ΠΈΠ±ΡΠΈΠ΄Π½ΡΠ΅ ΠΊΠΎΠΌΠ±ΠΈΠ½Π°ΡΠΈΠΈ F1, ΠΈΠ· ΠΊΠΎΡΠΎΡΡΡ
ΠΎΡΠΎΠ±ΡΠ°Π½Ρ Π»ΡΡΡΠΈΠ΅ Π΄Π»Ρ Π΄Π°Π»ΡΠ½Π΅ΠΉΡΠ΅ΠΉ ΡΠ΅Π»Π΅ΠΊΡΠΈΠΎΠ½Π½ΠΎΠΉ ΡΠ°Π±ΠΎΡΡ. Π ΠΈΡΠΎΠ³Π΅ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠΉ ΠΏΠΎΠ»ΡΡΠ΅Π½ Π½ΠΎΠ²ΡΠΉ ΠΈΡΡ
ΠΎΠ΄Π½ΡΠΉ ΠΌΠ°ΡΠ΅ΡΠΈΠ°Π» Π΄Π»Ρ ΡΠ΅Π»Π΅ΠΊΡΠΈΠΈ Π½ΠΎΠ²ΡΡ
ΡΠΎΡΡΠΎΠ² ΠΈ Π³ΠΈΠ±ΡΠΈΠ΄ΠΎΠ² Π΄ΡΠ½ΠΈ Ρ ΡΠ΅Π½Π½ΡΠΌΠΈ Ρ
ΠΎΠ·ΡΠΉΡΡΠ²Π΅Π½Π½ΡΠΌΠΈ ΠΏΡΠΈΠ·Π½Π°ΠΊΠ°ΠΌΠΈ. ΠΠΎΠ»ΡΡΠ΅Π½Π½ΡΠ΅ Π³ΠΈΠ±ΡΠΈΠ΄Π½ΡΠ΅ ΠΊΠΎΠΌΠ±ΠΈΠ½Π°ΡΠΈΠΈ F1 Π΄ΡΠ½ΠΈ Π±ΡΠ»ΠΈ ΠΈΡΠΏΡΡΠ°Π½Ρ Π½Π° ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΎΠ½Π½ΠΎΠΌ ΡΠΎΠ½Π΅. ΠΠΈΠ±ΡΠΈΠ΄Π½ΡΠ΅ ΠΊΠΎΠΌΠ±ΠΈΠ½Π°ΡΠΈΠΈ Ρ Π»ΡΡΡΠΈΠΌΠΈ ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»ΡΠΌΠΈ Π² Π΄Π°Π»ΡΠ½Π΅ΠΉΡΠ΅ΠΌ Π±ΡΠ΄ΡΡ ΠΈΠ·ΡΡΠ΅Π½Ρ Π² ΡΠ΅Π»Π΅ΠΊΡΠΈΠΎΠ½Π½ΠΎΠΌ ΠΏΠΈΡΠΎΠΌΠ½ΠΈΠΊΠ΅
- β¦